Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term
10:50am, Friday, 16'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Buy These 5 Price-to-Book Value Stocks for Gains in 2026
09:50am, Thursday, 15'th Jan 2026
Five low price-to-book stocks stand out for 2026, as undervalued valuations and solid growth outlooks put them on investors' radar.
4 Value Stocks to Buy As Wall Street Weighs Trump Policies
09:56am, Wednesday, 14'th Jan 2026
As markets reel from policy uncertainty, UHS, PNC, GPN, and BMRN emerge as compelling value picks with strong cash flow.
BioMarin Pharmaceutical touts $3.2B 2025 revenue, Voxzogo surge and Amicus deal at JPM Conference
04:04am, Wednesday, 14'th Jan 2026
BioMarin Pharmaceutical (NASDAQ: BMRN) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline strategic priorities for 2026, provide preliminary 2025 revenue figures, an
BMRN or TARS: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 13'th Jan 2026
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and Tarsus Pharmaceuticals, Inc. (TARS). But which of these two stocks is more
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
10:46am, Tuesday, 13'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is BioMarin Pharmaceutical (BMRN) a Great Value Stock Right Now?
10:41am, Tuesday, 13'th Jan 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
06:25pm, Monday, 12'th Jan 2026
BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
04:05pm, Monday, 12'th Jan 2026
Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical Industry
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
10:40am, Monday, 12'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Veeva und BioMarin schließen langfristige strategische Partnerschaft
06:07am, Friday, 09'th Jan 2026
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) und BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gaben eine langfristige Unternehmensvereinbarung bekannt, die auf
SAN RAFAEL, Calif., Jan. 8, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at th
Veeva y BioMarin forman una alianza estratégica a largo plazo
11:31am, Thursday, 08'th Jan 2026
/PRNewswire/ -- Veeva Systems (NYSE: VEEV) y BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) anunciaron un acuerdo empresarial a largo plazo que se basa en su
Veeva and BioMarin Form Long-Term Strategic Partnership
08:30am, Thursday, 08'th Jan 2026
Partnership to help BioMarin increase speed and efficiency in developing and commercializing innovative therapies PLEASANTON, Calif., and SAN RAFAEL, Calif.
10 Magnificent Stocks That Can Make You Richer in 2026
04:06am, Monday, 05'th Jan 2026
The stock market's major indexes delivered, once again, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all climbing to record highs in 2025. Regardless of whether the bull market
